Structural and functional analyses of three neutralizing antibodies against influenza virus H2 HA may explain why this HA subtype has disappeared from circulation in the human population and point to a potential new avenue for antiflu therapeutics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Molinari, N.A. et al. Vaccine 25, 5086–5096 (2007).
Taubenberger, J.K. & Kash, J.C. Cell Host Microbe 7, 440–451 (2010).
Nabel, G.J., Wei, C.J. & Ledgerwood, J.E. Nature 471, 157–158 (2011).
Dowdle, W.R. Bull. World Health Organ. 77, 820–828 (1999).
Xu, R. et al. Nat. Struct. Mol. Biol. 20, 363–370 (2013).
Julien, J.P., Lee, P.S. & Wilson, I.A. Immunol. Rev. 250, 180–198 (2012).
Hensley, S.E. et al. Science 326, 734–736 (2009).
Caton, A.J., Brownlee, G.G., Yewdell, J.W. & Gerhard, W. Cell 31, 417–427 (1982).
Wiley, D.C., Wilson, I.A. & Skehel, J.J. Nature 289, 373–378 (1981).
Yamada, A., Brown, L.E. & Webster, R.G. Virology 138, 276–286 (1984).
Krause, J.C. et al. J. Virol. 86, 6334–6340 (2012).
Kwong, P.D. & Wilson, I.A. Nat. Immunol. 10, 573–578 (2009).
Kelso, A. & Hurt, A.C. Nat. Med. 18, 1470–1471 (2012).
Kryazhimskiy, S., Dushoff, J., Bazykin, G.A. & Plotkin, J.B. PLoS Genet. 7, e1001301 (2011).
Ison, M.G. Curr. Opin. Virol. 1, 563–573 (2011).
Ortigoza, M.B. et al. PLoS Pathog. 8, e1002668 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brooke, C., Yewdell, J. Host versus flu: antibodies win a round?. Nat Struct Mol Biol 20, 245–246 (2013). https://doi.org/10.1038/nsmb.2524
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.2524